Internal Medicine Alert (Vol. 38, No. 16) - August 30, 2016

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: August 2016

Valid through: August 2019

Target Audience

This CME activity is intended for the internist/family physician.

Subjects

  • Too Little of a Good Thing Can Be a Bad Thing
  • Wheat Causes Intestinal Immune Activation in Some Patients Without Celiac Disease
  • Greater Weight Loss Later in Life Associated with Increased Risk of Mild Cognitive Impairment
  • Dual Antiplatelet Therapy Appears More Effective Than Single Therapy
  • Pharmacology Update: Lixisenatide Injection (Adlyxin)
  • Clinical Briefs: Vindication of Salmeterol- Fluticasone Single-inhaler Combination; Considering Perioperative Statins in Cardiac Surgery; Cocaine Use and Pyoderma Gangrenosum

Objectives

  • Describe new findings in differential diagnosis and treatment of various diseases
  • Describe the advantages, disadvantages and controversies surrounding the latest advances in the diagnosis and treatment of disease
  • Identify cost-effective treatment regimens
  • Explain the advantages and disadvantages of new disease screening procedures.

Credit Available

Physicians

  • Maximum of 2.0 AMA PRA Category 1 Credits
  • 2.0 AOA Category 2-B credits
  • 1.0 AAFP Credits
  • 2 American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) points

Sponsor

This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Physicians

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Osteopathic Association has approved this continuing education activity for up to 2.0 AOA Category 2-B credits.

Internal Medicine Alert has been reviewed and is acceptable for up to 1.0 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins Jan. 1, 2016. Term of approval is for one year from this date with the option of yearly renewal.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Faculty Listing

PHYSICIAN EDITOR

Stephen A. Brunton, MD

Adjunct Professor of Pharmacy Practice

College of Pharmacy

Roseman University of Health Sciences

Salt Lake City  

ASSOCIATE EDITORS

James Chan, PharmD, PhD

Pharmacy Quality and

Outcomes Manager, Kaiser

Permanente, Oakland, CA

 

William T. Elliott, MD, FACP

Chair, Formulary Committee

Northern California Kaiser

Permanente; Assistant Clinical

Professor of Medicine, University of California, San Francisco

 

Matthew E. Fink, MD

Professor and Chairman

Department of Neurology

Weill Cornell Medical College

Neurologist-in-Chief

New York Presbyterian Hospital

 

Makoto Ishii, MD, PhD

Assistant Professor of Neuroscience and Neurology

Feil Family Brain and Mind Research Institute

Department of Neurology

Weill Cornell Medical College

 

Louis Kuritzky, MD

Clinical Assistant Professor

University of Florida

Gainesville

 

Martin Lipsky, MD

Chancellor, South Jordan Campus

Roseman University of Health Sciences

South Jordan, UT

 

Joseph E. Scherger, MD, MPH

Vice President, Primary Care

Eisenhower Medical Center

Clinical Professor

Keck School of Medicine

University of Southern California

 

PEER REVIEWER

Gerald Roberts, MD

Senior Attending Physician

Long Island Jewish Medical Center

NS/LIJ Health Care System
New Hyde Park, NY

Financial Disclosure

Internal Medicine Alert’s Physician Editor Stephen Brunton, MD, is a retained consultant for Abbott Diabetes, Actavis, AstraZeneca, Becton Dickinson, Boehringer Ingelheim, Cempra, Janssen, Lilly, Merck, Novo Nordisk, Sanofi, and Teva; he serves on the speakers bureau of

AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, Novo Nordisk, and Teva. Contributing Editor Louis Kuritzky, MD, is a retained consultant for AbbVie, Allergan, AstraZeneca, Janssen, Lilly, Lundbeck, Medscape, Novo Nordisk, and Sanofi Aventis; he serves on the speakers bureau of Lilly and Lundbeck. Peer Reviewer Gerald Roberts, MD; Executive Editor Leslie Coplin; and Associate Managing Editor Jonathan Springston report no financial relationships relevant to this field of study.

Drs. Lipsky and Scherger report no financial relationships relevant to this field of study.

Dr. Fink reports he is a retained consultant for Proctor & Gamble and Pfizer.

Dr. Ishii reports he is a stockholder in Regeneron.

Copyright 2016, AHC Media. All rights reserved.